The National Institute of Health is offering a research grant to conduct epidemiologic research on emerging risk factors and their impact on liver cancer development in the United States. The grant aims to explore the interplay between new risk factors and established ones like viral hepatitis in hepatocellular carcinoma and other subtypes. Applications close on May 07, 2021.
Opportunity ID: 301011
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-18-677 |
Funding Opportunity Title: | Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 – Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 23, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2021 |
Current Closing Date for Applications: | May 07, 2021 |
Archive Date: | Jun 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments County governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-677.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238545 | May 05, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259052 | May 05, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
301011 RR_SF424_2_0-2.0.pdf
301011 PHS398_CoverPageSupplement_4_0-4.0.pdf
301011 RR_OtherProjectInfo_1_4-1.4.pdf
301011 PerformanceSite_2_0-2.0.pdf
301011 RR_KeyPersonExpanded_2_0-2.0.pdf
301011 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
301011 RR_Budget_1_4-1.4.pdf
301011 RR_SubawardBudget30_1_4-1.4.pdf
301011 PHS398_ModularBudget_1_2-1.2.pdf
301011 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
301011 RR_SF424_2_0-2.0.pdf
301011 PHS398_CoverPageSupplement_5_0-5.0.pdf
301011 RR_OtherProjectInfo_1_4-1.4.pdf
301011 PerformanceSite_2_0-2.0.pdf
301011 RR_KeyPersonExpanded_2_0-2.0.pdf
301011 PHS398_ResearchPlan_4_0-4.0.pdf
301011 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
301011 RR_Budget_1_4-1.4.pdf
301011 RR_SubawardBudget30_1_4-1.4.pdf
301011 PHS398_ModularBudget_1_2-1.2.pdf
301011 PHS_AssignmentRequestForm_3_0-3.0.pdf